- Advertisement -
- A new urine-based test can detect minimal residual bladder cancer after surgery and BCG treatment by analyzing tumour DNA in urine.
- The test can distinguish between those likely to be cured by surgery alone, those who could benefit from BCG immunotherapy, and those who do not respond and are at high risk of recurrence.
- Participants with detectable tumour DNA after completing BCG were…
